Back to Results
First PageMeta Content
Orphan drugs / Pyrimidines / Piperazines / Myeloid leukemia / Pyridines / Chronic myelogenous leukemia / Philadelphia chromosome / Nilotinib / Imatinib / Medicine / Oncology / Organic chemistry


Should nilotinib replace imatinib as first line treatment of chronic myeloid leukemia in chronic phase (CML-CP)? http://test.metromomsblog.org/wp-content/uploads[removed]tortoise-and-the-hare.jpg
Add to Reading List

Document Date: 2010-10-06 15:07:02

Open Document

File Size: 677,70 KB

Share Result on Facebook

City

San Antonio / /

Company

BP / Eastern Cooperative Oncology Group / /

Event

Product Issues / /

Facility

Austin College of Pharmacy / University of Texas / /

IndustryTerm

fusion product / treatment of chronic myeloid leukemia / /

MedicalCondition

insomnia / Phase Criteria Chronic / thrombocytosis / cancer / HIV / disease / Neutropenia / Nausea / Thrombocytopenia / chronic phase Previously / carcinoma / CML-chronic myeloid leukemia / Leukocytosis / fatigue / chronic phase / conclusions Chronic Myeloid Leukemia / diarrhea / carcinoma in situ / LUQ abdominal pain / chronic myeloid leukemia / Muscle cramps / depression / Rash / anemia / /

MedicalTreatment

major surgery / CCR / radiation / /

MusicGroup

Pyrexia / Nausea / /

Organization

Austin College / University of Texas at Austin / Pharmacy / TX Pharmacotherapy Education and Research Center / FDA / TX Division of Pharmacotherapy / /

Person

D. Van Nguyen / /

Position

Major / /

Product

Hydroxyurea / SC / cytarabine / CCR / DV / BP / DNA repair Figure / /

ProvinceOrState

Texas / /

RadioStation

Clarke FM / /

Region

South Texas / /

Technology

alpha / radiation / apoptosis / /

URL

http /

SocialTag